|
US4281061A
(en)
|
1979-07-27 |
1981-07-28 |
Syva Company |
Double antibody for enhanced sensitivity in immunoassay
|
|
US4709015A
(en)
|
1979-12-04 |
1987-11-24 |
Ortho Pharmaceutical Corporation |
Monoclonal antibody to human suppressor T cells
|
|
US5292668A
(en)
|
1981-12-21 |
1994-03-08 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5869620A
(en)
|
1986-09-02 |
1999-02-09 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
FR2604092B1
(en)
|
1986-09-19 |
1990-04-13 |
Immunotech Sa |
IMMUNOREACTIVES FOR TARGETING ANIMAL CELLS FOR VISUALIZATION OR DESTRUCTION IN VIVO
|
|
JP2682859B2
(en)
|
1987-07-27 |
1997-11-26 |
コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション |
Receptor membrane
|
|
GB8720833D0
(en)
|
1987-09-04 |
1987-10-14 |
Celltech Ltd |
Recombinant dna product
|
|
US4943525A
(en)
|
1987-11-02 |
1990-07-24 |
Bioventures, Inc. |
Simultaneous immunoassay for the determination of antigens and antibodies
|
|
US5869053A
(en)
|
1988-03-04 |
1999-02-09 |
Cancer Research Campaign Technology, Ltd. |
5T4 antigen from human trophoblasts
|
|
US4892824A
(en)
|
1988-03-15 |
1990-01-09 |
Synbiotics Corporation |
Fast track method for producing monoclonal bi-specific immunoglobulins
|
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
|
US5851527A
(en)
|
1988-04-18 |
1998-12-22 |
Immunomedics, Inc. |
Method for antibody targeting of therapeutic agents
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
WO1990005144A1
(en)
|
1988-11-11 |
1990-05-17 |
Medical Research Council |
Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
|
|
DE3920358A1
(en)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
|
|
US5980896A
(en)
|
1989-06-30 |
1999-11-09 |
Bristol-Myers Squibb Company |
Antibodies reactive with human carcinomas
|
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5582996A
(en)
|
1990-12-04 |
1996-12-10 |
The Wistar Institute Of Anatomy & Biology |
Bifunctional antibodies and method of preparing same
|
|
US6197298B1
(en)
|
1991-04-19 |
2001-03-06 |
Tanox, Inc. |
Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
|
|
DE4118120A1
(en)
|
1991-06-03 |
1992-12-10 |
Behringwerke Ag |
TETRAVALENT BISPECIFIC RECEPTORS, THEIR PRODUCTION AND USE
|
|
US5637481A
(en)
|
1993-02-01 |
1997-06-10 |
Bristol-Myers Squibb Company |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
|
|
DE4134982A1
(en)
|
1991-10-23 |
1993-04-29 |
Kernforschungsz Karlsruhe |
USE OF ANTIBODY-CONTAINING PREPARATIONS FOR IMMUNE SUPPRESSION
|
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
|
DE4140142A1
(en)
|
1991-12-05 |
1993-06-09 |
Boehringer Mannheim Gmbh, 6800 Mannheim, De |
MULTIVALENT DEXTRANREAGENT FOR USE IN PRECIPITATION TESTS
|
|
AU668374B2
(en)
|
1991-12-10 |
1996-05-02 |
Dana-Farber Cancer Institute |
Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof
|
|
WO1993011794A1
(en)
|
1991-12-13 |
1993-06-24 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
FR2686899B1
(en)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
|
|
EP1997894B1
(en)
|
1992-02-06 |
2011-03-30 |
Novartis Vaccines and Diagnostics, Inc. |
Biosynthetic binding protein for cancer marker
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US6096289A
(en)
|
1992-05-06 |
2000-08-01 |
Immunomedics, Inc. |
Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy
|
|
ZA936260B
(en)
|
1992-09-09 |
1994-03-18 |
Smithkline Beecham Corp |
Novel antibodies for conferring passive immunity against infection by a pathogen in man
|
|
EP1550729B1
(en)
|
1992-09-25 |
2009-05-27 |
Avipep Pty Limited |
Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain
|
|
US20080152586A1
(en)
|
1992-09-25 |
2008-06-26 |
Avipep Pty Limited |
High avidity polyvalent and polyspecific reagents
|
|
WO1994008038A1
(en)
|
1992-10-02 |
1994-04-14 |
Trustees Of Dartmouth College |
Bispecific reagents for redirected targeting of low density lipoprotein
|
|
US5837821A
(en)
|
1992-11-04 |
1998-11-17 |
City Of Hope |
Antibody construct
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
WO1994009820A1
(en)
|
1992-11-05 |
1994-05-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
WO1994012520A1
(en)
|
1992-11-20 |
1994-06-09 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
|
US5376249A
(en)
|
1992-11-25 |
1994-12-27 |
Perseptive Biosystems, Inc. |
Analysis utilizing isoelectric focusing
|
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
|
SG55079A1
(en)
|
1992-12-11 |
1998-12-21 |
Dow Chemical Co |
Multivalent single chain antibodies
|
|
US5861156A
(en)
|
1993-01-08 |
1999-01-19 |
Creative Biomolecules |
Methods of delivering agents to target cells
|
|
US5705614A
(en)
|
1993-04-09 |
1998-01-06 |
Chiron Corporation |
Methods of producing antigen forks
|
|
US20030108548A1
(en)
|
1993-06-01 |
2003-06-12 |
Bluestone Jeffrey A. |
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
|
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
|
US6001581A
(en)
|
1993-06-04 |
1999-12-14 |
Sibia Neurosciences, Inc. |
Cation-based bioassay using human metabotropic glutamate receptors
|
|
US5912122A
(en)
|
1993-06-04 |
1999-06-15 |
Sibia Neurosciences, Inc. |
Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6
|
|
US5521297A
(en)
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
|
US5869049A
(en)
|
1993-09-02 |
1999-02-09 |
Trustees Of Dartmouth College |
Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists
|
|
KR100398819B1
(en)
|
1993-09-02 |
2004-02-05 |
트러스티스 오브 다트마우스 칼리지 |
Pharmaceutical composition containing gp39 antagonist
|
|
FI961251A0
(en)
|
1993-09-20 |
1996-03-18 |
Ciba Geigy |
Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and to these related DNA compounds
|
|
US5935818A
(en)
|
1995-02-24 |
1999-08-10 |
Sloan-Kettering Institute For Cancer Research |
Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
GB9324807D0
(en)
|
1993-12-03 |
1994-01-19 |
Cancer Res Campaign Tech |
Tumour antibody
|
|
US7435802B2
(en)
|
1994-01-25 |
2008-10-14 |
Elan Pharaceuticals, Inc. |
Humanized anti-VLA4 immunoglobulins
|
|
WO1995022609A2
(en)
|
1994-02-21 |
1995-08-24 |
The Wellcome Foundation Limited |
Human glutamate receptor proteins
|
|
DE4421391C1
(en)
|
1994-06-18 |
1995-11-30 |
Gsf Forschungszentrum Umwelt |
Use of antibodies against T cells for prolonged immunosuppression
|
|
US5559099A
(en)
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
|
US5541087A
(en)
|
1994-09-14 |
1996-07-30 |
Fuji Immunopharmaceuticals Corporation |
Expression and export technology of proteins as immunofusins
|
|
US5688690A
(en)
|
1994-09-16 |
1997-11-18 |
The Wistar Institute Of Anatomy And Biology |
Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
|
|
CA2212846A1
(en)
|
1995-02-24 |
1996-08-29 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
GB9504344D0
(en)
|
1995-03-03 |
1995-04-19 |
Unilever Plc |
Antibody fragment production
|
|
US5747035A
(en)
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
AUPO591797A0
(en)
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
|
US5773292A
(en)
|
1995-06-05 |
1998-06-30 |
Cornell University |
Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
|
|
US5830478A
(en)
|
1995-06-07 |
1998-11-03 |
Boston Biomedical Research Institute |
Method for delivering functional domains of diphtheria toxin to a cellular target
|
|
US5977322A
(en)
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
|
WO1997014719A1
(en)
|
1995-10-16 |
1997-04-24 |
Unilever N.V. |
A bifunctional or bivalent antibody fragment analogue
|
|
ATE265532T1
(en)
|
1995-10-19 |
2004-05-15 |
Bristol Myers Squibb Co |
MONOCLONAL ANTIBODY BR110 AND ITS APPLICATION
|
|
US6084084A
(en)
|
1996-02-21 |
2000-07-04 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
|
US20040253246A1
(en)
|
1996-02-23 |
2004-12-16 |
Israeli Ron S. |
Prostate-specific membrane antigen and uses thereof
|
|
US6384205B1
(en)
|
1996-03-12 |
2002-05-07 |
Eli Lilly And Company |
Metabotropic glutamate receptor 4 nucleic acid
|
|
US6150508A
(en)
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
ATE318147T1
(en)
|
1996-03-25 |
2006-03-15 |
Medarex Inc |
SPECIFIC MONOCLONAL ANTIBODIES FOR THE EXTRACELLULAR DOMAIN OF PROTASTA-SPECIFIC MEMBRANE ANTIGEN
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
|
DE69724249T2
(en)
|
1996-05-23 |
2004-06-09 |
Inverness Medical Switzerland Gmbh |
IMPROVEMENTS IN OR WITH REGARD TO SPECIFIC BINDING ASSAYS
|
|
US6221609B1
(en)
|
1996-07-03 |
2001-04-24 |
Eli Lilly And Company |
Isolate nucleic acid encoding human MGLUR8
|
|
ATE465257T1
(en)
|
1996-07-03 |
2010-05-15 |
Genentech Inc |
HEPATOCYTE GROWTH FACTOR RECEPTOR AGONISTS AND THEIR APPLICATIONS
|
|
GB9712818D0
(en)
|
1996-07-08 |
1997-08-20 |
Cambridge Antibody Tech |
Labelling and selection of specific binding molecules
|
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
|
DE69719529T2
(en)
|
1996-10-17 |
2003-12-11 |
Immunomedics, Inc. |
NONANTANT TOXIN CONJUGATE AND FUSION PROTEIN IN AN INTERNALIZING RECEPTOR SYSTEM
|
|
WO1998029736A1
(en)
|
1996-12-31 |
1998-07-09 |
Genometrix Incorporated |
Multiplexed molecular analysis apparatus and method
|
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
|
EP0977837A1
(en)
|
1997-04-03 |
2000-02-09 |
Universite Laval |
Transgenic expression in genital tract and sexual accessory glands
|
|
ES2361267T3
(en)
|
1997-04-07 |
2011-06-15 |
Genentech Inc. |
PROCEDURE FOR THE PRODUCTION OF HUMANIZED ANTIBODIES THROUGH RANDOM MUTAGENESIS.
|
|
DE19721700C1
(en)
|
1997-05-23 |
1998-11-19 |
Deutsches Krebsforsch |
Mutant OKT3 antibody
|
|
AU8296098A
(en)
|
1997-07-08 |
1999-02-08 |
Board Of Regents, The University Of Texas System |
Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6994851B1
(en)
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6187284B1
(en)
|
1997-09-03 |
2001-02-13 |
Immunomedics, Inc. |
Fluorination of proteins and peptides for F-18 positron emission tomography
|
|
GB9720054D0
(en)
|
1997-09-19 |
1997-11-19 |
Celltech Therapeutics Ltd |
Biological products
|
|
US6030792A
(en)
|
1997-11-13 |
2000-02-29 |
Pfizer Inc |
Assays for measurement of protein fragments in biological media
|
|
US6709844B1
(en)
|
2000-11-16 |
2004-03-23 |
Mannkind Corporation |
Avoidance of undesirable replication intermediates in plasmid propagation
|
|
DE19911329A1
(en)
|
1998-03-27 |
2000-09-21 |
Benes Ivan Friedrich |
Radioimmunoconjugate which can be used in human therapy and process for its preparation
|
|
US7262280B1
(en)
|
1998-04-03 |
2007-08-28 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and constructs encoding same
|
|
CZ121599A3
(en)
|
1998-04-09 |
1999-10-13 |
Aventis Pharma Deutschland Gmbh |
A single chain molecule binding several antigens, a method for its preparation, and a drug containing the molecule
|
|
PT1071700E
(en)
|
1998-04-20 |
2010-04-23 |
Glycart Biotechnology Ag |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
|
US6200765B1
(en)
|
1998-05-04 |
2001-03-13 |
Pacific Northwest Cancer Foundation |
Non-invasive methods to detect prostate cancer
|
|
US6071490A
(en)
|
1998-05-07 |
2000-06-06 |
Immunomedics, Inc. |
Position emission tomography using gallium-68 chelates
|
|
EP1079862B1
(en)
|
1998-05-20 |
2010-07-07 |
Immunomedics, Inc. |
Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
|
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
|
DE69941187D1
(en)
|
1998-06-01 |
2009-09-10 |
Agensys Inc |
SERPENTINTRANSMEMBRANANTIGENE EXPRESSED IN HUMAN CANCER AND ITS USES
|
|
US7067109B1
(en)
|
1998-07-13 |
2006-06-27 |
Board Of Regents, The University Of Texas System |
Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
|
|
US6103524A
(en)
|
1998-07-30 |
2000-08-15 |
Eli Lilly And Company |
Metabotropic glutamate receptor protein and nucleic acid
|
|
AU5815699A
(en)
|
1998-09-08 |
2000-03-27 |
Urocor, Inc. |
Prostate specific promoter and regulation of gene expression
|
|
US6361774B1
(en)
|
1999-09-17 |
2002-03-26 |
Immunomedics, Inc. |
Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
|
|
US6284742B1
(en)
|
1998-09-29 |
2001-09-04 |
Uab Research Foundation |
Immunomodulation by genetic modification of dendritic cells and B cells
|
|
WO2000034461A2
(en)
|
1998-12-10 |
2000-06-15 |
Board Of Regents, The University Of Texas System |
Compositions and methods of modulating cholesterol metabolism
|
|
AU775583B2
(en)
|
1999-04-13 |
2004-08-05 |
Medarex, Inc. |
Methods for the diagnosis and treatment of metastatic prostate tumors
|
|
MXPA01010891A
(en)
|
1999-04-28 |
2002-11-07 |
Univ Texas |
Compositions and methods for cancer treatment by selectively inhibiting vegf.
|
|
US20090087878A9
(en)
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
WO2001009303A2
(en)
|
1999-07-30 |
2001-02-08 |
Vical Inc. |
Flt-3 LIGAND-ENCODING POLYNUCLEOTIDE AS A POLYNUCLEOTIDE-BASED VACCINE ENHANCER
|
|
KR100510795B1
(en)
|
1999-08-31 |
2005-08-30 |
|
Compositions and Methods for the Treatment of Tumor
|
|
US20040209314A1
(en)
|
1999-09-06 |
2004-10-21 |
Institut National De La Sante Et De La Recherche Medicale France |
Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
|
|
US6342587B1
(en)
|
1999-10-22 |
2002-01-29 |
Ludwig Institute For Cancer Research |
A33 antigen specific immunoglobulin products and uses thereof
|
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
|
CA2401252A1
(en)
|
2000-03-17 |
2001-09-20 |
Boehringer Ingelheim Pharma Kg |
Human and humanized fap-alpha-specific antibodies
|
|
US20040038339A1
(en)
|
2000-03-24 |
2004-02-26 |
Peter Kufer |
Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
|
|
US6608176B2
(en)
|
2000-03-31 |
2003-08-19 |
University Of Miami |
Taste receptor for umami (monosodium glutamate) taste
|
|
US6573096B1
(en)
|
2000-04-01 |
2003-06-03 |
The Research Foundation At State University Of New York |
Compositions and methods for inhibition of cancer invasion and angiogenesis
|
|
AU4430701A
(en)
|
2000-04-03 |
2001-10-15 |
Antisoma Research Limited |
Compounds for targeting
|
|
PT2857516T
(en)
|
2000-04-11 |
2017-08-28 |
Genentech Inc |
Multivalent antibodies and uses therefor
|
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
|
ES2347762T3
(en)
|
2000-04-28 |
2010-11-04 |
Mannkind Corporation |
SYNCHRONIZATION OF EPITHOPES IN CELLS THAT PRESENT ANTIGENS.
|
|
US7834146B2
(en)
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
|
US8106174B2
(en)
|
2000-05-08 |
2012-01-31 |
Monsanto Technology Llc |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
US6375991B1
(en)
|
2000-09-08 |
2002-04-23 |
Albemarle Corporation |
Production of concentrated biocidal solutions
|
|
DE10045591A1
(en)
|
2000-09-15 |
2002-04-04 |
Klaus Pfizenmaier |
Site-specific, antibody-mediated activation of proapoptotic cytokines - AMAIZe (Antibody-Mediated Apoptosis Inducing Cytokines)
|
|
IL158969A0
(en)
|
2001-06-01 |
2004-05-12 |
Cornell Res Foundation Inc |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7666414B2
(en)
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
US20030235833A1
(en)
|
2001-06-18 |
2003-12-25 |
National Institute Of Advanced Industrial Science And Technology |
Guanosine triphosphate-binding protein coupled receptors
|
|
US20030143668A1
(en)
|
2001-06-18 |
2003-07-31 |
National Institute Of Advanced Industrial |
Guanosine triphosphate-binding protein coupled receptors
|
|
CA2838062C
(en)
|
2001-08-03 |
2015-12-22 |
Roche Glycart Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
|
CN1142183C
(en)
|
2001-08-23 |
2004-03-17 |
北京大学人民医院 |
Anti-idiotype microantibody and its preparing process and application
|
|
AU2002336446B2
(en)
|
2001-09-06 |
2008-03-06 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
|
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US7192586B2
(en)
|
2001-09-20 |
2007-03-20 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
|
|
EP1445314B1
(en)
|
2001-10-23 |
2011-09-14 |
Ajinomoto Co., Inc. |
Novel glutamic acid receptor and utilization thereof
|
|
NZ532526A
(en)
|
2001-10-25 |
2007-01-26 |
Genentech Inc |
Compositions comprising a glycoprotein having a Fc region
|
|
GB0126378D0
(en)
|
2001-11-02 |
2002-01-02 |
Oxford Biomedica Ltd |
Antigen
|
|
EP1453471B1
(en)
|
2001-11-07 |
2011-01-05 |
Mannkind Corporation |
Expression vectors encoding epitopes of antigens and methods for their design
|
|
US20040018519A1
(en)
|
2001-11-16 |
2004-01-29 |
Wright ,Jr. George L |
Methods and devices for quantitative detection of prostate specific membrane antigen and other prostatic markers
|
|
WO2003062375A2
(en)
|
2001-12-19 |
2003-07-31 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
|
AU2003210802B2
(en)
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
EP1487879B1
(en)
|
2002-03-01 |
2012-12-26 |
Immunomedics, Inc. |
Bispecific antibody point mutations for enhancing rate of clearance
|
|
ATE477276T1
(en)
|
2002-03-01 |
2010-08-15 |
Immunomedics Inc |
INTERNALIZATION OF ANTI CD74 MONOCLONAL ANTIBODIES AND THEIR USES
|
|
EP1499353A4
(en)
|
2002-04-15 |
2006-04-05 |
Human Genome Sciences Inc |
Antibodies that specifically bind to tl5
|
|
WO2003089930A1
(en)
|
2002-04-22 |
2003-10-30 |
Georgetown University |
Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
|
|
JP4319979B2
(en)
|
2002-04-26 |
2009-08-26 |
ジェネンテック・インコーポレーテッド |
Non-affinity purification of proteins
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
US7993626B2
(en)
|
2007-01-11 |
2011-08-09 |
Immunomedics, Inc. |
Methods and compositions for F-18 labeling of proteins, peptides and other molecules
|
|
US7563433B2
(en)
|
2007-01-11 |
2009-07-21 |
Immunomedics, Inc. |
Methods and compositions for F-18 labeling of proteins, peptides and other molecules
|
|
US7597876B2
(en)
|
2007-01-11 |
2009-10-06 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
WO2004001004A2
(en)
|
2002-06-21 |
2003-12-31 |
Johns Hopkins University School Of Medicine |
Membrane associated tumor endothelium markers
|
|
CA2498264A1
(en)
|
2002-09-09 |
2004-05-13 |
Nura, Inc. |
G protein coupled receptors and uses thereof
|
|
US20080260744A1
(en)
|
2002-09-09 |
2008-10-23 |
Omeros Corporation |
G protein coupled receptors and uses thereof
|
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
|
US7820166B2
(en)
|
2002-10-11 |
2010-10-26 |
Micromet Ag |
Potent T cell modulating molecules
|
|
US9701754B1
(en)
|
2002-10-23 |
2017-07-11 |
City Of Hope |
Covalent disulfide-linked diabodies and uses thereof
|
|
AU2003293096B9
(en)
|
2002-11-27 |
2011-09-29 |
Biogen Ma Inc. |
Humanized antibodies against monocyte chemotactic proteins
|
|
US7534427B2
(en)
|
2002-12-31 |
2009-05-19 |
Immunomedics, Inc. |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
|
|
US7258971B2
(en)
|
2003-01-15 |
2007-08-21 |
Bayer Healthcare Ag |
Methods and compositions for treating urological disorders using carboxypeptidase Z identified as 8263
|
|
PL222220B1
(en)
|
2003-01-22 |
2016-07-29 |
Glycart Biotechnology Ag |
Host cell, method for producing a polypeptide in a host cell, antibody, antibody fragment, protein fusion, a pharmaceutical composition and method for treating cancer
|
|
CN1767860A
(en)
|
2003-01-31 |
2006-05-03 |
免疫医疗公司 |
Methods and compositions for administering therapeutic and diagnostic agents
|
|
EP1606313A2
(en)
|
2003-03-19 |
2005-12-21 |
Isogenis, Inc. |
Specific inhibition of allograft rejection
|
|
WO2004088279A2
(en)
|
2003-03-28 |
2004-10-14 |
Iowa State University Research Foundation, Inc. |
Allosteric probes and methods
|
|
GB0308988D0
(en)
|
2003-04-17 |
2003-05-28 |
Univ Singapore |
Molecule
|
|
US7541442B2
(en)
|
2003-05-30 |
2009-06-02 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
|
US7595379B2
(en)
|
2003-05-30 |
2009-09-29 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
|
WO2005014780A2
(en)
|
2003-05-30 |
2005-02-17 |
Agensys, Inc. |
Prostate stem cell antigen (psca) variants and subsequences thereof
|
|
AU2004242847B2
(en)
|
2003-05-31 |
2011-06-09 |
Amgen Research (Munich) Gmbh |
Pharmaceutical composition comprising a bispecific antibody for EpCAM
|
|
CA2523716C
(en)
|
2003-05-31 |
2014-11-25 |
Micromet Ag |
Human anti-human cd3 binding molecules
|
|
CN1822857A
(en)
|
2003-06-02 |
2006-08-23 |
阿莱克申药物公司 |
De-immunized anti-CD3 antibody
|
|
AU2004252171B2
(en)
|
2003-06-27 |
2011-04-21 |
Biogen Ma Inc. |
Modified binding molecules comprising connecting peptides
|
|
EP3095793B1
(en)
|
2003-07-28 |
2020-03-25 |
Genentech, Inc. |
Reducing protein a leaching during protein a affinity chromatography
|
|
GB0321805D0
(en)
|
2003-09-18 |
2003-10-15 |
Univ Wales Medicine |
Human tumour growth patterns
|
|
US20060134105A1
(en)
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
|
US7569389B2
(en)
|
2004-09-30 |
2009-08-04 |
Ceres, Inc. |
Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
|
|
US20120159672A1
(en)
|
2004-02-06 |
2012-06-21 |
Nickolai Alexandrov |
Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
|
|
US20060150283A1
(en)
|
2004-02-13 |
2006-07-06 |
Nickolai Alexandrov |
Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
|
|
US7524813B2
(en)
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
|
EP2292664B1
(en)
|
2003-10-16 |
2016-11-23 |
Amgen Research (Munich) GmbH |
Multispecific deimmunized CD3-binders
|
|
US20050176028A1
(en)
|
2003-10-16 |
2005-08-11 |
Robert Hofmeister |
Deimmunized binding molecules to CD3
|
|
EP2633866A3
(en)
|
2003-10-17 |
2013-12-18 |
Novo Nordisk A/S |
Combination therapy
|
|
ITPD20030264A1
(en)
|
2003-10-30 |
2005-04-30 |
Xeptagen Spa |
HIGHLY SPECIFIC DIAGNOSIS METHOD FOR NEOPLASIA
|
|
CN104998273A
(en)
|
2003-11-06 |
2015-10-28 |
西雅图基因公司 |
Monomethylvaline compounds capable of coupling to ligands
|
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
|
US9045739B2
(en)
|
2004-01-16 |
2015-06-02 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Immunokinases
|
|
US20060235212A1
(en)
|
2004-12-22 |
2006-10-19 |
Nickolai Alexandrov |
Nucleic acid sequences encoding zinc finger proteins
|
|
DE602005022830D1
(en)
|
2004-02-16 |
2010-09-23 |
Micromet Ag |
LESS IMMUNOGENOUS BONDING MOLECULES
|
|
AU2005216251B2
(en)
|
2004-02-23 |
2011-03-10 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
WO2005094882A1
(en)
|
2004-03-03 |
2005-10-13 |
Millennium Pharmaceuticals, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7273608B2
(en)
|
2004-03-11 |
2007-09-25 |
City Of Hope |
Humanized anti-CEA T84.66 antibody and uses thereof
|
|
JP4861308B2
(en)
|
2004-04-07 |
2012-01-25 |
ジェネンテック， インコーポレイテッド |
Mass spectrometry of antibody conjugates
|
|
NZ550816A
(en)
|
2004-04-22 |
2009-12-24 |
Agensys Inc |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
|
DE102004023187A1
(en)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
|
CA2567520A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Maytansinoid-antibody conjugates
|
|
WO2005118802A2
(en)
|
2004-06-03 |
2005-12-15 |
The Regents Of The University Of California |
Targeting pseudotyped retroviral vectors
|
|
US20050281740A1
(en)
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
|
US20060159689A1
(en)
|
2004-06-17 |
2006-07-20 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
|
CA2570990C
(en)
|
2004-07-16 |
2014-01-21 |
Micromet Ag |
Expression-enhanced polypeptides
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
EP3088004B1
(en)
|
2004-09-23 |
2018-03-28 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
US20080193376A1
(en)
|
2004-10-28 |
2008-08-14 |
The General Hospital Corporation |
Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation
|
|
US20080260650A1
(en)
|
2004-10-28 |
2008-10-23 |
The General Hospital Corporation |
Methods of Detection and Therapy of Inflamed Tissues Using Immune Modulation
|
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
|
US20070134243A1
(en)
|
2004-12-01 |
2007-06-14 |
Gazzard Lewis J |
Antibody drug conjugates and methods
|
|
US7335760B2
(en)
|
2004-12-22 |
2008-02-26 |
Ceres, Inc. |
Nucleic acid sequences encoding zinc finger proteins
|
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
|
KR101385886B1
(en)
|
2005-02-03 |
2014-04-24 |
안티토페 리미티드 |
Human antibodies and proteins
|
|
US7678371B2
(en)
|
2005-03-04 |
2010-03-16 |
Biogen Idec Ma Inc. |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
|
|
CN1854295A
(en)
|
2005-04-25 |
2006-11-01 |
上海新生源医药研究有限公司 |
Production of specific micro-antibody for oarium cancer
|
|
PE20061324A1
(en)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
|
GB2426581A
(en)
|
2005-05-27 |
2006-11-29 |
Univ Nottingham |
Immunoassay methods
|
|
JP2007014267A
(en)
|
2005-07-07 |
2007-01-25 |
Toyama Univ |
Monoclonal antibody against HBs antigen of hepatitis B virus, genes and peptides related thereto, hepatitis B virus assay method, hepatitis B diagnosis method, treatment method
|
|
WO2007009064A2
(en)
|
2005-07-11 |
2007-01-18 |
Macrogenics, Inc. |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
US20080279850A1
(en)
|
2005-07-25 |
2008-11-13 |
Trubion Pharmaceuticals, Inc. |
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
|
|
PT1912675E
(en)
|
2005-07-25 |
2014-05-09 |
Emergent Product Dev Seattle |
B-cell reduction using cd37-specific and cd20-specific binding molecules
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
WO2007100385A2
(en)
|
2005-10-31 |
2007-09-07 |
Genentech, Inc. |
Macrocyclic depsipeptide antibody-drug conjugates and methods
|
|
WO2007087673A1
(en)
|
2006-02-01 |
2007-08-09 |
Arana Therapeutics Limited |
Domain antibody construct
|
|
US20070212331A1
(en)
|
2006-03-07 |
2007-09-13 |
Baldassare Joseph J |
Methods and compositions for selectively killing cells
|
|
CA2646329C
(en)
|
2006-03-20 |
2018-07-03 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
|
MX2008012023A
(en)
|
2006-03-21 |
2008-10-01 |
Wyeth Corp |
Methods for preventing and treating amyloidogenic diseases.
|
|
EP2010216A4
(en)
|
2006-03-24 |
2010-06-09 |
Donald L Morton |
Mycobacterial immunotherapy for cancer treatment
|
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
|
US7566276B2
(en)
|
2006-04-14 |
2009-07-28 |
Dogleg Right Corporation |
Multi-piece putter head having an insert
|
|
WO2007137117A2
(en)
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
AR062223A1
(en)
|
2006-08-09 |
2008-10-22 |
Glycart Biotechnology Ag |
MOLECULES OF ADHESION TO THE ANTIGEN THAT ADHER TO EGFR, VECTORS THAT CODE THEM, AND THEIR USES OF THESE
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
CN101632020B
(en)
|
2006-09-13 |
2013-11-27 |
昂西免疫有限公司 |
Improved immunoassay method
|
|
RU2450832C2
(en)
|
2006-10-25 |
2012-05-20 |
Конинклейке Филипс Электроникс Н.В. |
Radiopaque substances for prostate cancer detection
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
WO2008079302A2
(en)
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification of proteins
|
|
US8128926B2
(en)
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
|
US8709382B2
(en)
|
2007-01-11 |
2014-04-29 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
CA2675202C
(en)
|
2007-01-11 |
2014-09-16 |
Immunomedics, Inc. |
Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
|
|
US8202509B2
(en)
|
2007-01-11 |
2012-06-19 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
US20150086482A1
(en)
|
2007-01-11 |
2015-03-26 |
Immunomedics, Inc. |
Dye Conjugated Peptides for Fluorescent Imaging
|
|
US8889100B2
(en)
|
2007-01-11 |
2014-11-18 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
US8545809B2
(en)
|
2007-01-11 |
2013-10-01 |
Immunomedics, Inc. |
Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
|
|
US20160045626A1
(en)
|
2007-01-11 |
2016-02-18 |
Immunomedics, Inc. |
Methods and Compositions for Improved Labeling of Targeting Peptides
|
|
WO2008127735A1
(en)
|
2007-04-13 |
2008-10-23 |
Stemline Therapeutics, Inc. |
Il3ralpha antibody conjugates and uses thereof
|
|
CA2682605A1
(en)
|
2007-04-18 |
2008-10-30 |
Zymogenetics, Inc. |
Single chain fc, methods of making and methods of treatment
|
|
KR20100021601A
(en)
|
2007-05-14 |
2010-02-25 |
바이오겐 아이덱 엠에이 인코포레이티드 |
Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
|
|
KR101580938B1
(en)
|
2007-06-01 |
2015-12-30 |
유니버시티 오브 매릴랜드, 발티모어 |
Immunoglobulin constant region Fc receptor binding agents
|
|
WO2009017823A2
(en)
|
2007-08-01 |
2009-02-05 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
A fold-back diabody diphtheria toxin immunotoxin and methods of use
|
|
CA2698343C
(en)
|
2007-09-04 |
2018-06-12 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
|
|
RU2526512C2
(en)
|
2007-09-26 |
2014-08-20 |
Чугаи Сейяку Кабусики Кайся |
Modified constant region of antibody
|
|
WO2009051769A1
(en)
|
2007-10-17 |
2009-04-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for crystallizing g protein-coupled receptors
|
|
DK2207564T3
(en)
|
2007-10-18 |
2017-01-16 |
Bavarian Nordic As |
USE OF VAT FOR TREATMENT OF PROSTATACANCES
|
|
JP2011501946A
(en)
|
2007-10-25 |
2011-01-20 |
ヴィヴェンティア バイオテクノロジーズ インコーポレーティッド |
Antibody against cancer-associated epitope of mutant HnRNPG and use thereof
|
|
US20100322861A1
(en)
|
2007-11-27 |
2010-12-23 |
Gambhir Sanjiv S |
Engineered cells, imaging report gene/probe systems, and methods of imaging
|
|
US9107858B2
(en)
|
2007-12-05 |
2015-08-18 |
Wisconsin Alumni Research Foundation |
Dendritic cell targeting compositions and uses thereof
|
|
WO2009097128A1
(en)
|
2008-01-29 |
2009-08-06 |
Ludwig Institute For Cancer Research Ltd. |
Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
|
|
US8043830B2
(en)
|
2008-02-01 |
2011-10-25 |
The Regents Of The University Of California |
Biotin-ligase system for secretion of biotinylated protein
|
|
US8742076B2
(en)
|
2008-02-01 |
2014-06-03 |
Genentech, Inc. |
Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
|
|
ITTO20080313A1
(en)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
ISOLATED MONOCLONAL ANTIBODY OR ITS FRAGMENT BINDING THE PROSTATE'S SPECIFIC MEMBRANE ANTIGEN, ITS CONJUGATES AND ITS USES
|
|
TW200947474A
(en)
|
2008-05-05 |
2009-11-16 |
Ren-Huan Pan |
Manufacturing equipment and method of quadratic arc alignment dua-turret formation center, and miniature milliohm current sensors manufactured thereof
|
|
EP2277044B1
(en)
|
2008-05-13 |
2015-06-17 |
Genentech, Inc. |
Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry
|
|
KR20110044991A
(en)
|
2008-07-02 |
2011-05-03 |
이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 |
TNP-α antagonist multi-target binding protein
|
|
US8728738B2
(en)
|
2008-07-02 |
2014-05-20 |
Assistance Publique-Hopitaux De Paris |
Method for predicting clinical outcome of patients with non-small cell lung carcinoma
|
|
US20110177070A1
(en)
*
|
2008-07-02 |
2011-07-21 |
Emergent Product Development Seatlle, LLC |
TGF-Beta Antagonist Multi-Target Binding Proteins
|
|
US8900589B2
(en)
|
2008-07-15 |
2014-12-02 |
Genetech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
|
US20100069616A1
(en)
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
|
JP5309775B2
(en)
|
2008-08-07 |
2013-10-09 |
セイコーエプソン株式会社 |
Discharge lamp driving device and driving method, light source device, and image display device
|
|
JP2012506695A
(en)
|
2008-08-20 |
2012-03-22 |
ヤンセン バイオテツク，インコーポレーテツド |
Modified anti-IL-13 antibodies, compositions, methods, and uses
|
|
WO2010027629A2
(en)
|
2008-09-08 |
2010-03-11 |
Conocophillips Company |
System for incondensable component separation in a liquefied natural gas facility
|
|
EP2334642B1
(en)
|
2008-09-16 |
2014-01-01 |
The Regents Of The University Of California |
Simplified one-pot synthesis of [18f]sfb for radiolabeling
|
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
|
NO2344540T3
(en)
|
2008-10-02 |
2018-04-28 |
|
|
|
NZ603623A
(en)
|
2008-10-10 |
2014-05-30 |
Emergent Product Dev Seattle |
Tcr complex immunotherapeutics
|
|
EP2356457B1
(en)
|
2008-10-13 |
2018-05-16 |
Xeptagen SPA |
Method for the preparation of immunoconjugates and use thereof
|
|
EP2358912B1
(en)
|
2008-10-30 |
2016-10-12 |
Caris Life Sciences Switzerland Holdings GmbH |
Methods for assessing rna patterns
|
|
CN102301002A
(en)
|
2008-11-12 |
2011-12-28 |
卡里斯生命科学卢森堡控股有限责任公司 |
Methods and systems for determining phenotypes using exosomes
|
|
EP2358390A1
(en)
|
2008-11-13 |
2011-08-24 |
Emergent Product Development Seattle, LLC |
Cd37 immunotherapeutic combination therapies and uses thereof
|
|
US20100143353A1
(en)
|
2008-12-04 |
2010-06-10 |
Mosser David M |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
|
|
US20110020327A1
(en)
|
2008-12-16 |
2011-01-27 |
Millipore Corporation |
Purification of proteins
|
|
DE112009001871B4
(en)
|
2008-12-25 |
2014-08-21 |
Tokai Rubber Industries, Ltd. |
Vibration damping device of the fluid-filled type
|
|
EP3543256A1
(en)
|
2009-01-12 |
2019-09-25 |
Cytomx Therapeutics Inc. |
Modified antibody compositions, methods of making and using thereof
|
|
BRPI1007371A2
(en)
|
2009-01-29 |
2018-03-27 |
Abbott Lab |
il-1 binding proteins
|
|
US10517969B2
(en)
|
2009-02-17 |
2019-12-31 |
Cornell University |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
US20120004289A1
(en)
|
2009-03-06 |
2012-01-05 |
The Johns Hopkins University |
Annexin a11 and associated genes as biomarkers for cancer
|
|
EP2995953B1
(en)
|
2009-03-24 |
2017-11-29 |
Biocept, Inc. |
Devices and methods of cell capture and analysis
|
|
CA2757897A1
(en)
|
2009-04-08 |
2010-10-14 |
Anna M. Wu |
Human protein scaffold with controlled serum pharmacokinetics
|
|
WO2010129304A2
(en)
|
2009-04-27 |
2010-11-11 |
Oncomed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
EA201190275A1
(en)
|
2009-05-28 |
2012-11-30 |
Глаксо Груп Лимитед |
PROTEIN CONNECTING INTERLEUKIN-13 (IL-13)
|
|
AR076796A1
(en)
|
2009-05-28 |
2011-07-06 |
Glaxo Group Ltd |
PROTEINS OF UNION TO THE ANTIGEN. PHARMACEUTICAL COMPOSITION USE. PROCESS.
|
|
JP2012531212A
(en)
|
2009-07-03 |
2012-12-10 |
アビペップ ピーティーワイ リミテッド |
Immunoconjugate and method for producing the same
|
|
WO2011003171A1
(en)
|
2009-07-08 |
2011-01-13 |
Smart Technologies Ulc |
Three-dimensional widget manipulation on a multi-touch panel
|
|
TWM383852U
(en)
|
2009-07-13 |
2010-07-01 |
Speedtech Corp |
An improvement of the universal serial bus connector
|
|
WO2011028952A1
(en)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
EP2471556A4
(en)
|
2009-10-05 |
2015-06-03 |
Canon Kk |
Contrast agent for photoacoustic imaging and photoacoustic imaging method utilizing same
|
|
WO2011067202A1
(en)
|
2009-12-02 |
2011-06-09 |
Unilever Nv |
Improved method for screening a potential modulator compound of a taste receptor
|
|
EP2506876B1
(en)
|
2009-12-02 |
2016-10-12 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
|
EP2516462B1
(en)
|
2009-12-23 |
2015-05-06 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
|
PT2519543T
(en)
|
2009-12-29 |
2016-10-07 |
Emergent Product Dev Seattle |
Heterodimer binding proteins and uses thereof
|
|
WO2011096894A2
(en)
|
2010-02-04 |
2011-08-11 |
Agency For Science Technology And Research |
Use of novel markers of pluripotent stem cells
|
|
US20130137975A1
(en)
|
2010-02-09 |
2013-05-30 |
OSI Pharmaceuticals, LLC |
Pet imaging
|
|
CA2791905A1
(en)
|
2010-03-01 |
2011-09-09 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Biomarkers for theranostics
|
|
UA108227C2
(en)
|
2010-03-03 |
2015-04-10 |
|
ANTIGENCY PROTEIN
|
|
US9812638B2
(en)
|
2010-03-19 |
2017-11-07 |
Globalfoundries Inc. |
Backend of line (BEOL) compatible high current density access device for high density arrays of electronic components
|
|
GB201014033D0
(en)
|
2010-08-20 |
2010-10-06 |
Ucb Pharma Sa |
Biological products
|
|
DK2611826T3
(en)
|
2010-08-30 |
2017-01-09 |
Confometrx Inc |
A method and composition for the crystallization of a family-C-GPCR
|
|
EP2556379B1
(en)
|
2010-10-28 |
2014-07-09 |
Avicenna Research Institute |
A 38 kda form of prelp as new diagnosis and therapeutic target
|
|
EP2471543A1
(en)
|
2010-12-02 |
2012-07-04 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
|
|
US20120144110A1
(en)
|
2010-12-02 |
2012-06-07 |
Lsi Corporation |
Methods and structure for storage migration using storage array managed server agents
|
|
EP2476754A1
(en)
|
2011-01-14 |
2012-07-18 |
Bundesrepublik Deutschland, Letztvertreten Durch Den Präsidenten Des Paul-Ehrlich-Instituts |
Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scFv)
|
|
WO2012097333A2
(en)
|
2011-01-14 |
2012-07-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
|
|
US20140170149A1
(en)
|
2011-04-20 |
2014-06-19 |
Genmab A/S |
Bispecific antibodies against her2 and cd3
|
|
EP2739312B1
(en)
|
2011-08-03 |
2017-10-04 |
Children's Medical Center Corporation |
A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
|
|
TWI679212B
(en)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
Binding molecules for e3 of bcma and cd3
|
|
GB201203051D0
(en)
|
2012-02-22 |
2012-04-04 |
Ucb Pharma Sa |
Biological products
|
|
GB201203071D0
(en)
|
2012-02-22 |
2012-04-04 |
Ucb Pharma Sa |
Biological products
|
|
EP2819704A4
(en)
|
2012-02-28 |
2015-10-21 |
Univ Cornell |
PSMA AS A BIOMARKER FOR ANDROGENIC ACTIVITY IN PROSTATE CANCER
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
EP2895203A4
(en)
|
2012-06-15 |
2016-09-28 |
Imaginab Inc |
ANTIGEN BINDING CONSTRUCTIONS FOR CD3
|
|
PE20150361A1
(en)
|
2012-07-13 |
2015-03-14 |
Roche Glycart Ag |
ANTI-VEGF / ANTI-ANG-2 BISPECIFIC ANTIBODIES AND THEIR USE IN THE TREATMENT OF EYE VASCULAR DISEASES
|
|
US20150191543A1
(en)
|
2012-08-06 |
2015-07-09 |
The Regents Of The University Of California |
Engineered antibody fragments for targeting and imaging cd8 expression in vivo
|
|
US9458245B2
(en)
|
2013-03-06 |
2016-10-04 |
Merrimack Pharmaceuticals, Inc. |
ANTI-C-MET tandem Fc bispecific antibodies
|
|
AU2014249243C1
(en)
|
2013-03-13 |
2019-08-08 |
Imaginab, Inc. |
Antigen binding constructs to CD8
|
|
US9168300B2
(en)
*
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
RS57393B1
(en)
|
2013-03-15 |
2018-09-28 |
Hoffmann La Roche |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
|
JP2016528167A
(en)
|
2013-04-29 |
2016-09-15 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Human FcRn binding modified antibody and method of use
|
|
CN105164157B
(en)
|
2013-04-29 |
2024-05-28 |
豪夫迈·罗氏有限公司 |
FC-receptor binding modified asymmetric antibodies and methods of use
|
|
EP3835318B1
(en)
|
2014-01-15 |
2025-10-29 |
F. Hoffmann-La Roche AG |
Fc-region variants with modified fcrn- and maintained protein a-binding properties
|
|
WO2015107015A1
(en)
|
2014-01-15 |
2015-07-23 |
F. Hoffmann-La Roche Ag |
Fc-region variants with improved protein a-binding
|
|
EP3094649A1
(en)
|
2014-01-15 |
2016-11-23 |
F. Hoffmann-La Roche AG |
Fc-region variants with modified fcrn-binding properties
|
|
JP6687247B2
(en)
|
2014-05-10 |
2020-04-22 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
Chemically immobilized bispecific antibody
|
|
EP2966085A1
(en)
|
2014-07-11 |
2016-01-13 |
Boehringer Ingelheim International GmbH |
Antibody IgG1 with a modified heavy chain constant region
|
|
WO2016016299A1
(en)
|
2014-07-29 |
2016-02-04 |
F. Hoffmann-La Roche Ag |
Multispecific antibodies
|
|
PT3283508T
(en)
|
2015-04-17 |
2021-06-21 |
Alpine Immune Sciences Inc |
IMMUNO MODULATORY PROTEINS WITH TUNING AFFINITIES
|
|
JP6985934B2
(en)
|
2015-04-29 |
2021-12-22 |
フレッド ハッチンソン キャンサー リサーチ センター |
Manipulated hematopoietic stem / progenitor cells and non-T effector cells, as well as their use
|
|
US11827904B2
(en)
|
2015-04-29 |
2023-11-28 |
Fred Hutchinson Cancer Center |
Modified stem cells and uses thereof
|
|
CN107847594B
(en)
|
2015-05-06 |
2022-04-15 |
詹森生物科技公司 |
Prostate-specific membrane antigen (PSMA) bispecific binding agents and uses thereof
|
|
US11820807B2
(en)
*
|
2015-06-12 |
2023-11-21 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
US20160362473A1
(en)
*
|
2015-06-12 |
2016-12-15 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
CA2984630A1
(en)
|
2015-07-07 |
2017-01-12 |
Immunomedics, Inc. |
Improved methods of imaging with ga-68 labeled molecules
|
|
CN108136012B
(en)
|
2015-08-07 |
2022-10-04 |
伊麦吉纳博公司 |
Antigen binding constructs for targeting molecules
|
|
MX2018003144A
(en)
|
2015-09-14 |
2018-09-11 |
Alpine Immune Sciences Inc |
Tunable variant immunoglobulin superfamily domains and engineered cell therapy.
|
|
WO2017059397A1
(en)
|
2015-10-01 |
2017-04-06 |
Whitehead Institute For Biomedical Research |
Labeling of antibodies
|
|
KR102693802B1
(en)
|
2016-02-15 |
2024-08-08 |
프라운호퍼-게젤샤프트 츄어 푀르더룽 데어 안게반텐 포르슝에.파우. |
Prevention of graft rejection by prior use of modified grafts
|
|
CN109476721B
(en)
|
2016-04-04 |
2022-06-28 |
英蒂分子公司 |
CD8-specific capture agents, compositions and methods of use and preparation
|
|
WO2017180587A2
(en)
|
2016-04-11 |
2017-10-19 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
WO2017186928A1
(en)
|
2016-04-29 |
2017-11-02 |
Curevac Ag |
Rna encoding an antibody
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
EP3266465A1
(en)
|
2016-07-06 |
2018-01-10 |
Julius-Maximilians-Universität Würzburg |
Immune complexes
|
|
WO2018053328A1
(en)
|
2016-09-16 |
2018-03-22 |
Duke University |
Bispecific molecules comprising an hiv-1 envelope targeting arm
|
|
RU2759952C2
(en)
|
2016-12-14 |
2021-11-19 |
Янссен Байотек, Инк. |
Cd8a-binding domains of iii fibronectin type
|
|
CN110418802A
(en)
|
2017-01-20 |
2019-11-05 |
朱诺治疗学有限公司 |
Cell surface conjugate and relevant cell composition and method
|
|
US11266745B2
(en)
|
2017-02-08 |
2022-03-08 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
WO2018187215A1
(en)
|
2017-04-03 |
2018-10-11 |
Merrimack Pharmaceuticals, Inc. |
Bispecific 4-1bb agonist molecules
|
|
CN111194221A
(en)
|
2017-05-10 |
2020-05-22 |
威斯塔解剖学和生物学研究所 |
Optimized nucleic acid antibody constructs
|
|
US11149094B2
(en)
*
|
2017-06-05 |
2021-10-19 |
Janssen Biotech, Inc. |
Engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations
|
|
CN111093693B
(en)
|
2017-06-15 |
2024-08-09 |
纪念斯隆-凯特林癌症中心 |
Anti-L1-CAM antibodies and uses thereof
|
|
WO2019012147A1
(en)
|
2017-07-13 |
2019-01-17 |
Institut Gustave-Roussy |
A radiomics-based imaging tool to monitor tumor-lymphocyte infiltration and outcome in cancer patients treated by anti-pd-1/pd-l1
|
|
WO2019023148A1
(en)
|
2017-07-24 |
2019-01-31 |
Regeneron Pharmaceuticals, Inc. |
Anti-cd8 antibodies and uses thereof
|
|
CN111511763B
(en)
|
2017-08-09 |
2024-05-31 |
奥里尼斯生物科学有限公司 |
CD8 binders
|
|
CN111295394B
(en)
|
2017-08-11 |
2024-06-11 |
豪夫迈·罗氏有限公司 |
Anti-CD8 antibodies and uses thereof
|
|
AU2018321893A1
(en)
|
2017-08-23 |
2020-03-19 |
Wayne State University |
In vivo immunoimaging of interferon-gamma
|
|
CN111372590A
(en)
|
2017-09-23 |
2020-07-03 |
纪念斯隆-凯特林癌症中心 |
A33 antibody compositions and methods of using the same in radioimmunotherapy
|
|
SG11202007513PA
(en)
|
2018-02-16 |
2020-09-29 |
Kite Pharma Inc |
Modified pluripotent stem cells and methods of making and use
|
|
EP3765031A4
(en)
|
2018-03-14 |
2022-03-23 |
Memorial Sloan Kettering Cancer Center |
ANTI-POLYSIALIC ACID ANTIBODIES AND THEIR USES
|
|
US12371497B2
(en)
|
2018-06-08 |
2025-07-29 |
Imaginab, Inc. |
Antigen binding constructs to CD4
|
|
JP2022501402A
(en)
|
2018-09-28 |
2022-01-06 |
イマジナブ・インコーポレーテッド |
CD8 Imaging Construct and How to Use It
|
|
WO2022169825A1
(en)
*
|
2021-02-03 |
2022-08-11 |
Mozart Therapeutics, Inc. |
Binding agents and methods of using the same
|